Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sally Beauty Holdings (SBH) Cash & Equivalents (2016 - 2025)

Historic Cash & Equivalents for Sally Beauty Holdings (SBH) over the last 17 years, with Q4 2025 value amounting to $157.2 million.

  • Sally Beauty Holdings' Cash & Equivalents rose 4895.1% to $157.2 million in Q4 2025 from the same period last year, while for Dec 2025 it was $157.2 million, marking a year-over-year increase of 4895.1%. This contributed to the annual value of $149.2 million for FY2025, which is 3816.29% up from last year.
  • Latest data reveals that Sally Beauty Holdings reported Cash & Equivalents of $157.2 million as of Q4 2025, which was up 4895.1% from $149.2 million recorded in Q3 2025.
  • Sally Beauty Holdings' 5-year Cash & Equivalents high stood at $408.3 million for Q1 2021, and its period low was $61.6 million during Q1 2023.
  • Over the past 5 years, Sally Beauty Holdings' median Cash & Equivalents value was $110.4 million (recorded in 2024), while the average stood at $158.8 million.
  • Per our database at Business Quant, Sally Beauty Holdings' Cash & Equivalents crashed by 8240.27% in 2022 and then surged by 7432.61% in 2023.
  • Sally Beauty Holdings' Cash & Equivalents (Quarter) stood at $298.1 million in 2021, then crashed by 66.77% to $99.1 million in 2022, then increased by 22.13% to $121.0 million in 2023, then decreased by 12.79% to $105.5 million in 2024, then skyrocketed by 48.95% to $157.2 million in 2025.
  • Its Cash & Equivalents stands at $157.2 million for Q4 2025, versus $149.2 million for Q3 2025 and $112.8 million for Q2 2025.